eISSN: 2084-9869
ISSN: 1233-9687
Polish Journal of Pathology
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

without publication fees
3/2024
vol. 75
 
Share:
Send email
Share:
abstract:
Original paper

The role of the CLL-1 protein in disease monitoring in patients diagnosed with acute myeloid leukaemia and myelodysplastic syndrome

Ewa Dobak
1
,
Sylwia Romana Jankowska-Szabłowska
1
,
Renata Guzicka-Kazimierczak
2
,
Paulina Poter
3
,
Elżbieta Urasińska
1
,
Katarzyna Karpińska-Łukaszewicz
1

  1. Department of Pathology, Pomeranian Medical University, Szczecin, Poland
  2. Department of Haematology and Transplantology, Pomeranian Medical University, Szczecin, Poland
  3. Department of Tumour Pathology, Greater Poland Cancer Centre, Poznań, Poland
Pol J Pathol 2024; 75 (3):182-191
DOI: https://doi.org/10.5114/pjp.2024.143228
Online publish date: 2024/10/16
View full text Get citation
 
PlumX metrics:
The normal subpopulation of CD34+CD38 – haematopoietic stem cells does not express CLL-1; therefore, the assessment of the expression of this protein can be used for the diagnosis of minimal residual disease. The aim of this study was to evaluate, using multi-colour flow cytometry, the level of CLL-1 protein expression on CD34+CD38- myeloid niche cells in acute myeloid leukaemia (AML) and myelodysplastic syndromepatients at the time of diagnosis and during disease monitoring on the example of 3 practical cases. The following conclusion was drawn: CD34+CD38-CLL-1+ cells in AML patients may serve as a biomarker to predict disease aggressiveness.
keywords:

AML, CLL-1, MDS, multi-colour flow cytometry
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.